Evaluation of 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 as a Therapeutic Agent for Androgen-dependent Prostate Cancer
Saved in:
Published in | Anticancer research Vol. 29; no. 9; pp. 3547 - 3553 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Conference Proceeding |
Language | English |
Published |
Attiki
International Institute of Anticancer Research
01.09.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0250-7005 1791-7530 |
---|